(Total Views: 362)
Posted On: 10/11/2017 11:47:27 AM
Post# of 124
AYTU-DD = Market Cap $18 M / Cash $11.8 M / 4 Marketed Products one of them Natesto targeting $2 BILLION Market / Shares Out only 4.22 M ..After doing my dd i can say for sure this unknown stock is a brutal gift at this price .This low float stock should be valued at minimum $120-150 Million (~$30-35 per share ) right now for their marketed products .GL
Market Cap : $18 Million
Cash $11.8 Million
Price $4.20
Shares Out 4.22 Million
Presentation
http://aytubio.com/downloads/Aytu-Corporate-Overview.pdf
Fact Sheet
http://aytubio.com/downloads/Aytu-Corporate-Fact-Sheet.pdf
Marketed Products:
•Natesto–testosterone nasal gel indicated for hypogonadism ($2 billion market in the U.S., 13 million men diagnosed with hypogonadism (low testosterone)
•MiOXSYS–in vitro device for male infertility ($825 million International market ,30 million men impacted in U.S.)
•Fiera–pre-intimacy device to increase sexual desire and arousal in women (53 million women in the U.S. with sexual concerns)
•ProstaScint–imaging agent for prostate cancer
Aytu BioScience (AYTU) Stock: Why This Thing Can Grow Legs!
https://cnafinance.com/aytu-bioscience-aytud-...legs/16622
Aytu BioScience, Inc.(OTCMKTS: AYTU) is a stock that we've covered in great detail as of late, and for good reason. The company is in the prime position to take charge of a massive industry with hundreds of millions if not billions of dollars in potential revenue. Today, we'll get into one of the many reasons that we're so bullish with regard to AYTU, a reason that can be summed up in a single word, Natesto
Market Cap : $18 Million
Cash $11.8 Million
Price $4.20
Shares Out 4.22 Million
Presentation
http://aytubio.com/downloads/Aytu-Corporate-Overview.pdf
Fact Sheet
http://aytubio.com/downloads/Aytu-Corporate-Fact-Sheet.pdf
Marketed Products:
•Natesto–testosterone nasal gel indicated for hypogonadism ($2 billion market in the U.S., 13 million men diagnosed with hypogonadism (low testosterone)
•MiOXSYS–in vitro device for male infertility ($825 million International market ,30 million men impacted in U.S.)
•Fiera–pre-intimacy device to increase sexual desire and arousal in women (53 million women in the U.S. with sexual concerns)
•ProstaScint–imaging agent for prostate cancer
Aytu BioScience (AYTU) Stock: Why This Thing Can Grow Legs!
https://cnafinance.com/aytu-bioscience-aytud-...legs/16622
Aytu BioScience, Inc.(OTCMKTS: AYTU) is a stock that we've covered in great detail as of late, and for good reason. The company is in the prime position to take charge of a massive industry with hundreds of millions if not billions of dollars in potential revenue. Today, we'll get into one of the many reasons that we're so bullish with regard to AYTU, a reason that can be summed up in a single word, Natesto
(0)
(0)Scroll down for more posts ▼
